author-photo

Kara Yannotti

Hackensack University Medical Center

4

Papers

58

Citations

Citation Trend

Filter By

Papers (4) Sort By

Journal Conference Others

Phase Ib-II Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib, w/ Lenalidomide and Rituximab in Relapsed / Refractory Mantle Cell Lymphoma

2017 Blood
Show All
- Source
- Cite
- Save
Citations (1)
A Phase I/II Study of Reduced Dose FCR (FCR-lite) in Combination with Lenalidomide Followed By Lenalidomide Maintenance (FCR2) for Initial Therapy of CLL: Final Results and Long-Term Follow-up

2017 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Reduced‐dose fludarabine, cyclophosphamide, and rituximab (FCR‐Lite) plus lenalidomide, followed by lenalidomide consolidation/maintenance, in previously untreated chronic lymphocytic leukemia

2015 American Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (22)
Addition of lenalidomide to rituximab, ifosfamide, carboplatin, etoposide (RICER) in first-relapse/primary refractory diffuse large B-cell lymphoma

2014 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (35)